p.99 抽出テキスト

mechanisms for maldevelopment of the heart, pancreas, and diaphragm. Elife 2020; 9: e53278. PMID: 33054971 192. Yagi H, Furutani Y, Hamada H, et al. Role of TBX 1 in human del 22q 11. 2 syndrome. Lancet 2003; 362: 1366- 1373. PMID: 14585638 193. Smemo S, Campos LC, Moskowitz IP, et al. Regulatory variation in a TBX 5 enhancer leads to isolated congenital heart disease. Hum Mol Genet 2012; 21: 3255-3263. PMID: 22543974 194. Griffin HR, Töpf A, Glen E, et al. Systematic survey of variants in TBX 1 in non-syndromic tetralogy of Fallot identifies a novel 57 base pair deletion that reduces transcriptional activity but finds no evidence for association with common variants. Heart 2010; 96: 1651-1655. PMID: 20937753 195. Kirk EP, Sunde M, Costa MW, et al. Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy. Am J Hum Genet 2007; 81: 280-291. PMID: 17668378 196. Zhou YM, Dai XY, Huang RT, et al. A novel TBX20 lossoffunction mutation contributes to adultonset dilated cardiomyopathy or congenital atrial septal defect. Mol Med Rep 2016; 14: 3307- 3314. PMID: 27510170 197. Huang RT, Wang J, Xue S, et al. TBX20 loss-of-function mutation responsible for familial tetralogy of Fallot or sporadic persistent truncus arteriosus. Int J Med Sci 2017; 14: 323- 332. PMID: 28553164 198. McDaniell R, Warthen DM, Sanchez-Lara PA, et al. NOTCH 2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am J Hum Genet 2006; 79: 169-173. PMID: 16773578 199. Stittrich AB, Lehman A, Bodian DL, et al. Mutations in NOTCH1 cause Adams-Oliver syndrome. Am J Hum Genet 2014; 95: 275-284. PMID: 25132448 200. Garg V, Muth AN, Ransom JF, et al. Mutations in NOTCH1 cause aortic valve disease. Nature 2 0 0 5 ; 4 3 7 : 2 7 0 - 2 7 4 . PMID: 16025100 201. Kerstjens-Frederikse WS, van de Laar IM, Vos YJ, et al. Cardiovascular malformations caused by NOTCH 1 mutations do not keep left: data on 428 probands with left-sided CHD and their families. Genet Med 2016; 18: 914-923. PMID: 26820064 202. McBride KL, Riley MF, Zender GA, et al. NOTCH1 mutations in individuals with left ventricular outflow tract malformations reduce ligand-induced signaling. Hum Mol Genet 2008; 17: 2886- 2893. PMID: 18593716 203. Roessler E, Ouspenskaia MV, Karkera JD, et al. Reduced NODAL signaling strength via mutation of several pathway members including FOXH1 is linked to human heart defects and holoprosencephaly. Am J Hum Genet 2008; 83: 18-29. PMID: 18538293 204. Goldmuntz E, Bamford R, Karkera JD, et al. CFC 1 mutations in patients with transposition of the great arteries and double-outlet right ventricle. Am J Hum Genet 2002; 70: 776- 780. PMID: 11799476 205. Karkera JD, Lee JS, Roessler E, et al. Loss-of-function mutations in growth differentiation factor- 1 (GDF 1) are associated with congenital heart defects in humans. Am J Hum Genet 2007; 81: 987-994. PMID: 17924340 206. Wang B, Yan J, Mi R, et al. Forkhead box H1 (FOXH1) sequence variants in ventricular septal defect. Int J Cardiol 2010; 145: 83-85. PMID: 19525021 207. De Luca A, Sarkozy A, Consoli F, et al. Familial transposition of the great arteries caused by multiple mutations in laterality genes. Heart 2010; 96: 673-677. PMID: 19933292 208. Ching YH, Ghosh TK, Cross SJ, et al. Mutation in myosin heavy chain 6 causes atrial septal defect. Nat Genet 2005; 37: 423-428. PMID: 15735645 209. Carniel E, Taylor MR, Sinagra G, et al. α-myosin heavy chain: A sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy. Circulation 2005; 112: 54- 59. PMID: 15998695 210. Budde BS, Binner P, Waldmüller S, et al. Noncompaction of the ventricular myocardium is associated with a de novo mutation in the β-myosin heavy chain gene. PLoS One 2007; 2: e1362. PMID: 18159245 211. Postma AV, van Engelen K, van de Meerakker J, et al. Mutations in the sarcomere gene MYH 7 in Ebstein anomaly. Circ Cardiovasc Genet 2011; 4: 43-50. PMID: 21127202 212. Matsson H, Eason J, Bookwalter CS, et al. Alpha-cardiac actin mutations produce atrial septal defects. Hum Mol Genet 2008; 17: 256-265. PMID: 17947298 213. Monserrat L, Hermida-Prieto M, Fernandez X, et al. Mutation in the alpha-cardiac actin gene associated with apical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects. Eur Heart J 2007; 28: 1953-1961. PMID: 17611253 214. Zhu L, Vranckx R, Khau Van Kien P, et al. Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat Genet 2006; 38: 343-349. PMID: 16444274 215. Geisterfer-Lowrance AA, Kass S, Tanigawa G, et al. A molecular basis for familial hypertrophic cardiomyopathy: a β cardiac myosin heavy chain gene missense mutation. Cell 1990; 62: 999-1006. PMID: 1975517 216. Alfares AA, Kelly MA, McDermott G, et al. Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity. Genet Med 2015; 17: 880-888. PMID: 25611685 217. Otsuka H, Arimura T, Abe T, et al. Prevalence and distribution of sarcomeric gene mutations in Japanese patients with familial hypertrophic cardiomyopathy. Circ J 2012; 76: 453-461. PMID: 22112859 218. 日本循環器学会/ 日本心不全学会.心筋症診療ガイドライン(2018 年改訂版).https://www.j-circ.or.jp/cms/wp-content/uploads/2018/08/ JCS2018_tsutsui_kitaoka.pdf 219. Ommen SR, Mital S, Burke MA, et al. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/ American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2020; 142: e558-e631. PMID: 33215931 220. Elliott PM, Anastasakis A, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014; 35: 2733-2779. PMID: 25173338 221. Bagnall RD, Ingles J, Dinger ME, et al. Whole Genome Sequencing Improves Outcomes of Genetic Testing in Patients With Hypertrophic Cardiomyopathy. J Am Coll Cardiol 2018; 72: 419-429. PMID: 30025578 222. Ingles J, Goldstein J, Thaxton C, et al. Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes. Circ Genom Precis Med 2019; 12: e002460. PMID: 30681346 223. Harper AR, Goel A, Grace C, et al. HCMR Investigators. Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity. Nat Genet 2021; 53: 135-142. PMID: 33495597 224. Jensen MK, Havndrup O, Christiansen M, et al. Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing. Circulation 2013; 127: 48-54. PMID: 23197161 225. Lorenzini M, Norrish G, Field E, et al. Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers. J Am Coll Cardiol 2020; 76: 550-559. PMID: 32731933 226. Ingles J, Burns C, Bagnall RD, et al. Nonfamilial Hypertrophic Cardiomyopathy: Prevalence, Natural History, and Clinical Implications. Circ Cardiovasc Genet 2017; 10: e001620. PMID: 28408708 227. Nakashima Y, Kubo T, Sugiura K, et al. Lifelong Clinical Impact of the Presence of Sarcomere Gene Mutation in Japanese Patients With Hypertrophic Cardiomyopathy. Circ J 2020; 84: 1846-1853. PMID: 32830170 228. Kubo T, Kitaoka H, Okawa M, et al. Lifelong left ventricular remodeling of hypertrophic cardiomyopathy caused by a founder frameshift deletion mutation in the cardiac Myosin-binding protein C gene among Japanese. J Am Coll Cardiol 2005; 46: 1737- 1743. PMID: 16256878 229. Bos JM, Will ML, Gersh BJ, et al. Characterization of a phenotype-based genetic test prediction score for unrelated patients with hypertrophic cardiomyopathy. Mayo Clin Proc 2014; 89: 727-737. PMID: 24793961 230. Moriki T, Kubo T, Sugiura K, et al. A Validation Study of the Mayo Clinic Phenotype-Based Genetic Test Prediction Score for Japanese Patients With Hypertrophic Cardiomyopathy. Circ J 2021; 85: 669-674. PMID: 33487615 230a. 森田啓行. 遺伝子から心筋症をみる.日内会誌 2014; 103: 285-292. 231. Nishiuchi S, Makiyama T, Aiba T, et al. Gene-Based Risk Stratification for Cardiac Disorders in LMNA Mutation Carriers. Circ Cardiovasc Genet 2017; 10: e001603. PMID: 29237675 232. Rootwelt-Norberg C, Christensen AH, Skjølsvik ET, et al. Timing of cardioverter-defibrillator implantation in patients with cardiac laminopathies-External validation of the LMNA-risk ventricular tachyarrhythmia calculator. Heart Rhythm 2023; 20: 423- 429. PMID: 36494026 233. Tobita T, Nomura S, Fujita T, et al. Genetic basis of cardiomyopathy and the genotypes involved in prognosis and left ventricular